Sunday, July 18, 2021 9:26:08 AM
I do want to point out that Jason did seek help last Summer. The Maxim agreement is dated August 28th which helps with uplist and other financial efforts for one. Also, the name that hasn’t been heard for a long time is Omkhar Arasaratnam. He has a one year consulting agreement which expires this month. It appears that what has happened this past year has been structured toward the stated goal with the debt clean-up and reverse split. I would expect that Omkhar Arasaratnam had some input concerning the last group of acquisitions. Jason needs actual board members other than himself so I am wondering if this person is a prospect given the serious need for credibility here. I see two payments with shares in early February to consultants in the annual 10K which could have easily converted for over $40K each at that time.
Maxim Agreement
https://sec.report/Document/0001493152-20-017237/
https://www.otcmarkets.com/stock/ATDSD/news/Data443-Risk-Mitigation-Inc-Engages-Maxim-Group-LLC-to-Assist-with-its-Growth-Strategy-and-Goal-to-Up-list-to-a-National?id=272681
DATA443 RISK MITIGATION WELCOMES MR. OMKHAR ARASARATNAM TO ITS ADVISORY BOARD
https://www.otcmarkets.com/stock/ATDSD/news/DATA443-RISK-MITIGATION-WELCOMES-MR-OMKHAR-ARASARATNAM-TO-ITS-ADVISORY-BOARD?id=269031
https://sec.report/Document/0001493152-20-014876/
“Effective July 28, 2020, the company entered into an Advisory Board Agreement (the “Advisory Agreement”) with Omkharan Arasaratnam (the “Advisor”). Pursuant to the Advisory Agreement, the Advisor joined the Advisory Board of the Company for a term of 12-months, although either party may terminate the Advisory Agreement early upon proper notice. The Company agreed to issue to the Advisor five million (5,000,000) shares of its common stock to the Advisor, which shares shall vest at the rate of 25% every 3-months under the Advisory Agreement. The issuance was exempt under Section 4(a)(2) of the Securities Act.”
Recent ATDS News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2023 08:05:42 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/29/2023 09:25:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:13:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/24/2023 09:27:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/06/2023 09:18:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/06/2023 09:17:40 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM